Challenges in management of Candida auris meningitis secondary to infected ventriculoperitoneal shunt - A case report.

Autor: Sridharan S; Apollo Hospitals, India. Electronic address: kesowmya@yahoo.com., Govindaswamy A; Apollo Proton Cancer Centre, India. Electronic address: dr.aishwaryagovind@gmail.com., Rajendran A; Apollo Proton Cancer Centre, India. Electronic address: adhithyan40@gmail.com., Roopesh Kumar VR; Apollo Proton Cancer Centre, India. Electronic address: roops1975@gmail.com.
Jazyk: angličtina
Zdroj: Indian journal of medical microbiology [Indian J Med Microbiol] 2024 Mar-Apr; Vol. 48, pp. 100555. Date of Electronic Publication: 2024 Mar 08.
DOI: 10.1016/j.ijmmb.2024.100555
Abstrakt: Meningitis in patients with ventriculo-peritoneal shunt (VP shunt) caused by various species of Candida have been widely described in literature. However, reports describing Candida auris as a cause of meningitis is limited. In this case report we describe a case of multidrug resistant Candida auris meningitis secondary to VP shunt infection successfully treated with intrathecal amphotericin B deoxycholate and intravenous liposomal amphotericin B. This is the second case report of successful treatment of Candida auris meningitis from India. More literature regarding the use of intrathecal/intraventricular echinocandins including optimal dosing and duration of therapy is needed.
Competing Interests: Declaration of competing interest Nil.
(Copyright © 2024 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: